01—Abstract
Summary
Summary of the 8-K filed January 10, 2025. Cited figures are marked; the original filing is the authoritative source.
Labcorp Holdings Inc. (NYSE: LH) filed a Current Report on Form 8-K dated January 10, 2025, under Item 7.01 (Regulation FD Disclosure).
The filing announces that members of the company's executive management team will take part in a fireside chat at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, at 3:45 p.m. (PT).
The filing is a routine investor-relations notice rather than a financial disclosure. It does not report financial results, guidance, or material transactions. Investors who want to hear management's remarks can access a live audio webcast through the company's Investor Relations website at ir.Labcorp.com, with a replay archived there afterward.
The accompanying press release (Exhibit 99.1) describes Labcorp as a global leader in laboratory services. It states that the company has more than 60,000 employees, serves clients in over 100 countries, worked on over 80%a of the new drugs approved by the FDA in 2022, and performed more than 600 million tests for patients worldwide.
02—Key points
Key Highlights
- Labcorp executive management will participate in a fireside chat at the 43rd Annual J.P. Morgan Healthcare Conference on January 14, 2025, at 3:45 p.m. (PT).
- A live audio webcast of the fireside chat will be available on the Investor Relations website (ir.Labcorp.com) and archived for replay.
- The filing is a Regulation FD disclosure under Item 7.01 and contains no financial results, guidance, or transaction details.
- The press release (Exhibit 99.1) states Labcorp has more than 60,000 employees and serves clients in over 100 countries.
- According to the press release, Labcorp worked on over 80% of the new drugs approved by the FDA in 2022.
- According to the press release, Labcorp performed more than 600 million tests for patients around the world.
03—Questions
Frequently Asked Questions
Why did Labcorp file this 8-K?
The company filed under Item 7.01 (Regulation FD Disclosure) to publicly announce that its executive management will speak at the J.P. Morgan Healthcare Conference, which ensures all investors receive the information at the same time.
When and how can investors listen to the fireside chat?
The fireside chat is scheduled for Tuesday, January 14, at 3:45 p.m. (PT). A live audio webcast will be available at ir.Labcorp.com, and the chat will be archived there for replay.
Does this filing contain financial results or guidance?
No. The filing only announces the conference appearance and furnishes a press release that describes the company's business. It does not include financial results, earnings guidance, or other financial metrics.
What does the press release say about Labcorp's scale?
The press release states that Labcorp has more than 60,000 employees, serves clients in over 100 countries, worked on over 80% of the new drugs approved by the FDA in 2022, and performed more than 600 million tests for patients around the world.
04—Continue